Home Healthcare Biotechnology Natural Killer (NK) Cell Therapeutics Market

Natural Killer (NK) Cell Therapeutics Market Size, Share & Trends Analysis Report By Product (CAR-NK Cell Therapies, NK Cell-directed Antibodies), By Indication (Oncology, Infectious Diseases, Autoimmune Diseases, Gastrointestinal Diseases, Other Indications), By End User (Hospitals & Clinics, Research & Academic Institutes, Other End Users) and By Country (U.S., Canada) Forecasts, 2026-2034

Last Updated: July 09, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR4226DR | Pages: 150
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Natural Killer (NK) Cell Therapeutics Market Size Analysis
    1. Introduction
    2. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. CAR-NK Cell Therapies
      2. NK Cell-directed Antibodies
    3. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Infectious Diseases
      3. Autoimmune Diseases
      4. Gastrointestinal Diseases
      5. Other Indications
    4. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Research & Academic Institutes
      3. Other End Users
  7. North America Natural Killer (NK) Cell Therapeutics Market Size Analysis
    1. Introduction
    2. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. CAR-NK Cell Therapies
      2. NK Cell-directed Antibodies
    3. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Infectious Diseases
      3. Autoimmune Diseases
      4. Gastrointestinal Diseases
      5. Other Indications
    4. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Research & Academic Institutes
      3. Other End Users
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
  8. Europe Natural Killer (NK) Cell Therapeutics Market Size Analysis
    1. Introduction
    2. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. CAR-NK Cell Therapies
      2. NK Cell-directed Antibodies
    3. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Infectious Diseases
      3. Autoimmune Diseases
      4. Gastrointestinal Diseases
      5. Other Indications
    4. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Research & Academic Institutes
      3. Other End Users
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    7. France
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
  9. APAC Natural Killer (NK) Cell Therapeutics Market Size Analysis
    1. Introduction
    2. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. CAR-NK Cell Therapies
      2. NK Cell-directed Antibodies
    3. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Infectious Diseases
      3. Autoimmune Diseases
      4. Gastrointestinal Diseases
      5. Other Indications
    4. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Research & Academic Institutes
      3. Other End Users
    5. China
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    8. India
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
  10. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size Analysis
    1. Introduction
    2. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. CAR-NK Cell Therapies
      2. NK Cell-directed Antibodies
    3. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Infectious Diseases
      3. Autoimmune Diseases
      4. Gastrointestinal Diseases
      5. Other Indications
    4. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Research & Academic Institutes
      3. Other End Users
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
  11. LATAM Natural Killer (NK) Cell Therapeutics Market Size Analysis
    1. Introduction
    2. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. CAR-NK Cell Therapies
      2. NK Cell-directed Antibodies
    3. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Infectious Diseases
      3. Autoimmune Diseases
      4. Gastrointestinal Diseases
      5. Other Indications
    4. Natural Killer (NK) Cell Therapeutics Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Research & Academic Institutes
      3. Other End Users
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. CAR-NK Cell Therapies
        2. NK Cell-directed Antibodies
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Autoimmune Diseases
        4. Gastrointestinal Diseases
        5. Other Indications
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research & Academic Institutes
        3. Other End Users
  12. Competitive Landscape
    1. Natural Killer (NK) Cell Therapeutics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Fate Therapeutics
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Nkarta Therapeutics
    3. Century Therapeutics
    4. Glycostem Therapeutics
    5. Artiva Biotherapeutics
    6. Affimed N.V.
    7. Innate Pharma
    8. Dragonfly Therapeutics
    9. GT Biopharma
    10. ImmunityBio
    11. Acepodia
    12. Bristol-Myers Squibb
    13. Novartis
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.